Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co LlcfiledCriticalPharmacia & Upjohn Co Llc
Publication of CR8900ApublicationCriticalpatent/CR8900A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
La presente invencion se refiere a nuevos derivados oxazolidinonas de oxindoles de formula I, o una sal farmaceuticamente aceptable de las mismas en la que Y1 es -CH- o -CF-; R1 es -alquilo (C1-C4), sustituido opcionalmente con un atomo de fluoro, o R1 es -cicloalquilo (C3-C5); y R2 es -H o -CH3. Estos compuestos son utiles como agentes antibacterianos.The present invention relates to novel oxazolidinone derivatives of oxindoles of formula I, or a pharmaceutically acceptable salt thereof in which Y1 is -CH- or -CF-; R1 is - (C1-C4) alkyl, optionally substituted with a fluoro atom, or R1 is - (C3-C5) alkyl; and R2 is -H or -CH3. These compounds are useful as antibacterial agents.
CR8900A2004-08-062007-02-05
OXAZOLIDINONES CONTAINING OXINDOLS AS AGENTS
CR8900A
(en)
ARILSULFONAMIDAS 2,5-DISUSTITUID ANTAGONISTAS OF CCR3, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE OF THE SAME FOR THE TREATMENT AND / OR PREVENTION OF AUTOIMMUNE AND INFLAMMATORY PATHOLOGIES, BETWEEN OTHER.